Maha Rashtra Apex Corporation Q4 FY26: Losses Deepen Amid Revenue Collapse

3 hours ago
share
Share Via
Maha Rashtra Apex Corporation Ltd., a micro-cap non-banking financial company (NBFC), reported deeply troubling fourth-quarter results for FY26, with consolidated net losses widening to ₹4.96 crores—a staggering 201.02% sequential deterioration from Q3 FY26's profit of ₹4.91 crores. The company's revenue base virtually collapsed, with net sales plummeting 96.95% quarter-on-quarter to just ₹0.06 crores in Q4 FY26, down from ₹1.97 crores in the previous quarter. Trading at ₹50.00 with a market capitalisation of ₹137.00 crores, the stock has declined 1.40% following the results announcement, extending its one-year losses to 23.29%.
Maha Rashtra Apex Corporation Q4 FY26: Losses Deepen Amid Revenue Collapse
Consolidated Net Loss (Q4 FY26)
₹4.96 Cr
▼ 201.02% QoQ
Net Sales (Q4 FY26)
₹0.06 Cr
▼ 96.95% QoQ | ▼ 80.00% YoY
Operating Margin (Excl OI)
-816.67%
Q4 FY26
Stock Price (May 27, 2026)
₹50.00
▼ 1.40% (1D)

The results paint a picture of a company in severe operational distress. The standalone net loss for Q4 FY26 stood at ₹0.47 crores, whilst profit before tax collapsed to negative ₹4.56 crores from a positive ₹5.23 crores in Q3 FY26. With operating profit before depreciation, interest, and tax (excluding other income) at negative ₹0.49 crores—the lowest in recent quarters—the company's core business operations are haemorrhaging cash. The dramatic revenue contraction, coupled with persistent employee costs of ₹0.23 crores, has resulted in an operating margin of negative 816.67%, signalling fundamental business model challenges.

This micro-cap NBFC, with roots dating back to 1943 when it was incorporated as Maharashtra Apex Bank Limited, has undergone multiple transformations—from banking to hire-purchase operations following its 1955 name change. Now trading at a price-to-book value of just 0.31x against a market capitalisation of ₹137.00 crores, the company's distressed valuation reflects deep investor concerns about its viability. The stock's technical indicators remain mildly bearish, with the price trading below all major moving averages, whilst shareholding patterns show promoters increasing their stake to 71.57% in May 2026 from 62.54% in the previous quarter—a 9.03 percentage point increase that suggests either confidence or defensive positioning.

Quarter Net Sales (₹ Cr) QoQ Change Cons. Net Profit (₹ Cr) QoQ Change Operating Margin (%)
Mar'26 (Q4) 0.06 ▼ 96.95% -4.96 ▼ 201.02% -816.67%
Dec'25 (Q3) 1.97 ▲ 3183.33% 4.91 ▼ 116.00% 71.57%
Sep'25 (Q2) 0.06 ▲ 20.00% -30.69 ▼ 228.63% -750.00%
Jun'25 (Q1) 0.05 ▼ 83.33% 23.86 ▲ 6.52% -860.00%
Mar'25 (Q4) 0.30 ▲ 500.00% 22.40 ▼ 429.41% -50.00%
Dec'24 (Q3) 0.05 ▼ 89.58% -6.80 ▼ 14.68% -700.00%
Sep'24 (Q2) 0.48 -7.97 -93.75%

Financial Performance: A Catastrophic Quarter

The fourth quarter of FY26 represents one of the most challenging periods in recent memory for Maha Rashtra Apex Corporation. Net sales of ₹0.06 crores in Q4 FY26 marked a 96.95% sequential decline from ₹1.97 crores in Q3 FY26, whilst year-on-year comparisons show an 80.00% contraction from ₹0.30 crores in Q4 FY25. This near-total revenue evaporation has left the company unable to cover even its basic operating expenses, with employee costs alone at ₹0.23 crores consuming nearly four times the quarter's revenue.

Operating profit before depreciation, interest, and tax (excluding other income) stood at negative ₹0.49 crores in Q4 FY26, representing the lowest level across recent quarters and translating to an operating margin of negative 816.67%. The company's reliance on other income—which contributed ₹0.33 crores in Q4 FY26—has become critical to softening losses, though this non-operating income source remains volatile and insufficient to offset operational shortfalls. The profit before tax collapsed to negative ₹4.56 crores from positive ₹5.23 crores in the previous quarter, whilst the consolidated net loss widened to ₹4.96 crores from a profit of ₹4.91 crores quarter-on-quarter.

Net Sales (Q4 FY26)
₹0.06 Cr
▼ 96.95% QoQ | ▼ 80.00% YoY
Consolidated Net Loss
₹4.96 Cr
▼ 201.02% QoQ
Operating Margin (Excl OI)
-816.67%
Q4 FY26
PAT Margin
-8266.67%
Q4 FY26

On an annual basis, FY25 results showed net sales of ₹1.00 crore—an 87.50% decline from ₹8.00 crores in FY24. Despite this revenue collapse, the company managed to report a profit after tax of ₹11.00 crores for FY25, primarily driven by extraordinary other income of ₹6.00 crores and exceptional items contributing to profit before tax of ₹339.00 crores. However, this annual profitability masks the underlying operational deterioration evident in quarterly trends, with the business model showing no sustainable revenue generation capability.

Critical Operational Warning

Revenue Collapse: Net sales have declined 96.95% quarter-on-quarter to just ₹0.06 crores, representing a near-total evaporation of business activity. With employee costs at ₹0.23 crores consuming nearly four times quarterly revenue, the company faces severe cash burn and sustainability concerns.

Negative Operating Leverage: Operating profit excluding other income stands at negative ₹0.49 crores with margins at negative 816.67%, indicating fundamental business model challenges that cannot be resolved through cost-cutting alone.

Balance Sheet Concerns: Eroding Shareholder Value

Whilst Maha Rashtra Apex Corporation maintains a debt-free balance sheet with zero long-term borrowings as of March 2025, the erosion of shareholder value through persistent losses raises serious concerns about capital preservation. Shareholder funds stood at ₹465.84 crores as of March 2025, up from ₹445.94 crores in March 2024, primarily due to reserves increasing to ₹451.72 crores. However, the recent quarterly losses suggest this capital base is under severe pressure, with the Q4 FY26 consolidated loss of ₹4.96 crores alone representing approximately 1.06% erosion of shareholder funds.

The company's investment portfolio stood at ₹516.16 crores as of March 2025, up from ₹507.01 crores in the previous year, representing the bulk of total assets. This heavy concentration in investments—whilst generating some other income—raises questions about asset productivity and the company's ability to deploy capital in revenue-generating operations. Current assets of ₹21.30 crores and minimal fixed assets of ₹0.09 crores underscore the company's transformation from an operational NBFC to essentially an investment holding vehicle with negligible lending or financing activities.

The company's return on equity (ROE) averaged 15.17% over the long term, though the latest quarterly ROE has turned negative at -0.05%, reflecting the recent loss-making quarters. Return on capital employed (ROCE) similarly stands at a deeply negative -0.31%, indicating that the company is destroying value rather than creating it through its operational activities. With a book value per share of ₹172.11 against a market price of ₹50.00, the stock trades at a steep 71% discount to book value—a clear signal that investors believe the carrying value of assets may not be fully realisable or that future losses will further erode equity.

NBFC Sector Context: An Outlier in Distress

Within the broader NBFC sector, Maha Rashtra Apex Corporation stands as a stark outlier. Whilst the industry delivered a 7.85% return over the past year, Maha Rashtra Apex has underperformed by 31.14 percentage points with a negative 23.29% return. This massive underperformance reflects not just cyclical challenges but fundamental business model failure. The company's asset under management (AUM) growth, disbursement activities, and core lending operations—the lifeblood of any NBFC—appear to have ceased, with quarterly revenues barely registering.

The NBFC sector has generally benefited from India's credit growth story, with most players expanding loan books, improving asset quality, and maintaining healthy net interest margins. Maha Rashtra Apex, by contrast, appears to have exited active lending altogether, with its revenue base collapsing to negligible levels. The company's transformation from a banking entity in 1943 to a hire-purchase company in 1955 and subsequently to its current form suggests multiple failed business pivots, with the latest incarnation showing no viable path to sustainable profitability.

Company P/E (TTM) P/BV ROE (%) Debt/Equity
Maha Rashtra Apex 12.26 0.31 15.17 0.00
Keynote Financial 16.65 1.01 11.97 0.01
Pioneer Investcorp 8.53 0.89 3.53 0.43
Supra Pacific 18.93 1.93 2.59 3.77
Reliable Data 12.78 2.31 11.97 0.59
Trustedgecapital 258.04 2.52 2.16 0.18

Compared to peers, Maha Rashtra Apex trades at the lowest price-to-book value of 0.31x versus a peer average of approximately 1.77x, reflecting severe investor scepticism. Whilst the company's historical ROE of 15.17% appears competitive against peers averaging around 6%, this backward-looking metric masks the current reality of negative returns and operational losses. The company's zero debt position, whilst superficially attractive, actually reflects an inability to deploy leverage profitably—a critical capability for any financial services company.

Valuation Analysis: Distressed Asset Pricing

At ₹50.00 per share, Maha Rashtra Apex Corporation trades at a price-to-earnings ratio of 12.26x based on trailing twelve-month earnings—a metric that may prove misleading given recent quarterly losses. The price-to-book value of 0.31x represents a 69% discount to book value, pricing in substantial risk of further capital erosion or asset write-downs. The company's enterprise value-to-EBITDA multiple of 138.86x appears absurdly high, though this reflects the near-zero EBITDA base rather than premium valuation.

The stock's valuation grade has oscillated wildly, moving from "Very Expensive" to "Very Attractive" and back multiple times between July and August 2025, before settling at "Very Expensive" currently. This volatility in valuation assessment reflects the difficulty in assigning fair value to a company with no sustainable earnings stream and highly erratic quarterly results. The 52-week trading range of ₹37.80 to ₹75.06 shows the stock currently 33.39% below its high and 32.28% above its low, with technical indicators suggesting limited near-term upside.

P/E Ratio (TTM)
12.26x
Industry: 21x
Price to Book Value
0.31x
69% discount to book
Market Cap
₹137 Cr
Micro Cap
Mojo Score
13/100
STRONG SELL

With zero institutional holdings and negligible retail interest reflected in daily volumes of just 1,513 shares, the stock suffers from severe illiquidity. The absence of foreign institutional investors (FIIs), mutual funds, and insurance companies from the shareholder register signals that professional investors have abandoned the stock entirely. This lack of institutional support, combined with the company's operational distress, creates a valuation environment where book value provides little downside protection, as asset realisations in a distressed scenario rarely achieve carrying values.

Shareholding Dynamics: Promoter Accumulation Amid Decline

A notable development in the May 2026 quarter was the significant increase in promoter shareholding from 62.54% to 71.57%—a 9.03 percentage point jump. This accumulation, occurring against the backdrop of deteriorating financial performance, raises questions about promoter intentions. Whilst increased promoter stake can signal confidence, in this context it may also represent defensive positioning to maintain control or prevent hostile actions given the company's distressed state.

Quarter Promoter % Change FII % MF % Non-Inst %
May'26 71.57% +9.03% 0.00% 0.00% 28.43%
Mar'26 62.54% 0.00% 0.00% 37.45%
Dec'25 62.54% 0.00% 0.00% 37.45%
Sep'25 62.54% 0.00% 0.00% 37.45%
Jun'25 62.54% 0.00% 0.00% 37.45%

The promoter group is dominated by Manipal Holdings Private Limited (20.38%), Metropolis Builders Pvt Ltd (15.48%), and Jaya S Pai (13.33%), with no pledging of shares reported. Non-institutional shareholding declined correspondingly from 37.45% to 28.43%, suggesting retail investors are exiting whilst promoters accumulate. The complete absence of institutional investors—zero FII, mutual fund, or insurance company holdings—represents a damning vote of no confidence from professional fund managers who typically provide liquidity and valuation support to small-cap stocks.

Stock Performance: Sustained Underperformance Across Timeframes

Maha Rashtra Apex Corporation's stock performance has been dismal across virtually all timeframes, with the exception of very long-term returns. The stock has declined 23.29% over the past year, underperforming the Sensex by 16.40 percentage points. Over two years, losses extend to 38.62%, whilst three-year returns show a decline of 9.04% against the Sensex's 21.50% gain—a negative alpha of 30.54 percentage points. Only the ten-year return of 729.68% shows significant outperformance, though this largely reflects a low base effect from historical lows rather than recent value creation.

Period Stock Return Sensex Return Alpha
1 Week +5.29% +0.82% +4.47%
1 Month -3.25% -1.77% -1.48%
3 Months +0.64% -6.58% +7.22%
6 Months +4.84% -11.41% +16.25%
YTD -12.11% -10.89% -1.22%
1 Year -23.29% -6.89% -16.40%
2 Years -38.62% +0.72% -39.34%
3 Years -9.04% +21.50% -30.54%

The stock's risk-adjusted return over one year stands at negative 0.37 with volatility of 62.74%—classifying it as "HIGH RISK LOW RETURN". This represents the worst possible combination for investors: substantial downside volatility without commensurate upside potential. The stock's beta of 1.50 indicates it is 50% more volatile than the broader market, amplifying losses during market downturns whilst failing to participate meaningfully in rallies. Trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), the technical picture remains firmly bearish with the trend classified as "Mildly Bearish" since May 13, 2026.

Investment Thesis: Severe Distress Signals

The investment case for Maha Rashtra Apex Corporation has deteriorated dramatically, with the company's Mojo Score plummeting to 13 out of 100—firmly in "STRONG SELL" territory. This score reflects multiple concurrent red flags: a negative financial trend, mildly bearish technical indicators, "Very Expensive" valuation despite the low absolute price, and "Below Average" quality assessment. The company's quality grade has been downgraded to "Does Not Qualify" as of February 2026, indicating it fails to meet minimum standards for investability based on long-term financial performance.

Valuation Grade
Very Expensive
Despite low absolute price
Quality Grade
Below Average
Does Not Qualify (Feb'26)
Financial Trend
Negative
Since Mar'26
Technical Trend
Mildly Bearish
Since 13-May-26

The company's five-year sales growth of negative 0.66% and five-year EBIT growth of 9.03% mask the recent operational collapse, with quarterly revenues now virtually non-existent. The cash flow statement for FY25 shows negative operating cash flow of ₹4.00 crores, indicating the company is burning cash from core operations and relying on investment liquidations and financing activities to maintain liquidity. With closing cash of just ₹3.00 crores as of March 2025 against quarterly losses exceeding ₹4.96 crores, the runway for continued operations appears severely limited without a dramatic business model transformation.

Key Concerns Limiting the Score

✗ Stock in bearish technical trend with price below all major moving averages

✗ Negative financial trend with Q4 FY26 marking lowest PBDIT in recent quarters

✗ Operating losses rendering the company fundamentally weak with no sustainable revenue base

✗ Underperformed the market by 16.40 percentage points over the past year

✗ Zero institutional holdings signalling complete absence of professional investor confidence

Key Strengths & Risk Factors

KEY STRENGTHS

Debt-Free Balance Sheet: Zero long-term borrowings provide financial flexibility without interest burden

Substantial Investment Portfolio: Investments of ₹516.16 crores represent potential liquidity source

Increased Promoter Stake: Promoters raised holding to 71.57% from 62.54%, up 9.03 percentage points

Historical ROE: Long-term average ROE of 15.17% demonstrates past profitability capability

Low Valuation: Trading at 0.31x book value offers significant discount to stated asset values

KEY CONCERNS

⚠️ Revenue Collapse: Q4 FY26 sales of ₹0.06 crores down 96.95% QoQ represents business model failure

⚠️ Persistent Losses: Consolidated net loss of ₹4.96 crores in Q4 FY26 with negative operating margins

⚠️ Zero Institutional Interest: Complete absence of FII, mutual fund, or insurance holdings

⚠️ Negative Cash Generation: Operating cash flow negative ₹4.00 crores in FY25

⚠️ Quality Downgrade: Company rated "Does Not Qualify" since February 2026

⚠️ Severe Illiquidity: Daily volumes of just 1,513 shares limit exit options

⚠️ Technical Weakness: Trading below all moving averages with mildly bearish trend

Outlook: Critical Monitoring Points

POSITIVE CATALYSTS

• Material improvement in quarterly revenue generation above ₹1.00 crore sustainably

• Return to positive operating margins excluding other income

• Concrete business model articulation with visible path to profitability

• Entry of institutional investors or strategic partners signalling turnaround confidence

RED FLAGS

• Further sequential revenue decline or sustained sub-₹0.50 crore quarterly sales

• Quarterly losses exceeding ₹5.00 crores indicating accelerating cash burn

• Depletion of cash reserves below ₹1.00 crore raising going concern questions

• Forced asset liquidations at distressed valuations to fund operations

• Regulatory actions or compliance issues given NBFC status

"With quarterly revenues collapsing to just ₹0.06 crores and operating margins at negative 816.67%, Maha Rashtra Apex Corporation faces an existential crisis requiring immediate and radical business model transformation."

The path forward for Maha Rashtra Apex Corporation remains highly uncertain. The company's transformation from a banking entity to hire-purchase operations and subsequently to its current incarnation suggests a pattern of failed business pivots. Without a clear articulation of strategy, visible revenue generation capability, or institutional investor support, the investment case remains deeply challenged. The promoter stake increase to 71.57% may signal commitment to turnaround efforts, but concrete evidence of operational improvement remains absent.

For existing shareholders, the decision to hold or exit depends critically on risk tolerance and belief in management's ability to execute a turnaround. The 69% discount to book value provides some mathematical downside protection, though asset realisations in distressed scenarios rarely achieve carrying values. The complete absence of institutional investors and severe illiquidity mean exit options are limited, with significant price impact likely on any material selling. Fresh investors should avoid the stock entirely until clear evidence emerges of sustainable revenue generation and a return to positive operating margins.

The Verdict: Distressed Asset Requiring Radical Transformation

STRONG SELL

Score: 13/100

For Fresh Investors: Avoid entirely. The company exhibits all characteristics of a distressed asset with no visible path to sustainable profitability. Revenue collapse, persistent losses, zero institutional interest, and severe illiquidity create an unfavourable risk-reward profile. Wait for concrete evidence of business model viability before considering any position.

For Existing Holders: Consider exiting on any price strength, though severe illiquidity may necessitate patient execution. The 69% discount to book value provides limited comfort given the risk of further capital erosion through continued losses. Only hold if you have high conviction in management's unstated turnaround plan and can withstand potential total loss of capital.

Fair Value Estimate: Given the absence of sustainable earnings, fair value is difficult to estimate. Book value of ₹172.11 per share provides an upper bound, though realisation at even 50% of book (₹86.00) appears optimistic. Current price of ₹50.00 may represent 40-50% downside to distressed asset value of ₹25-30 per share if operational losses continue.

Note— ROCE = (EBIT - Other Income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. The views expressed are based on publicly available information and the author's analysis, which may be subject to change. Past performance is not indicative of future results, and investments in securities involve risk of loss.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News